You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PDGFR-alpha

Showing 1 - 25 of 2,797
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GIST, GIST, Malignant, PDGFR-Alpha D842V Trial in France (Patient treated by Avapritinib in real life)

Recruiting
  • GIST
  • +2 more
  • Patient treated by Avapritinib in real life
  • Besançon, France
  • +5 more
Jun 9, 2021

FLT3-ITD Mutation, FLT3/TKD Mutation, PDGFR-Alpha D842V Trial in Genova (Crenolanib besylate)

Available
  • FLT3-ITD Mutation
  • +3 more
  • Crenolanib besylate
  • Genova, Italy
    Ospedale Policlinico San Martino
May 21, 2020

Leiomyosarcoma, Liposarcoma, Soft Tissue Sarcoma Adult Trial in Taipei (Eribulin, Lenvatinib)

Active, not recruiting
  • Leiomyosarcoma
  • +3 more
  • Taipei, Taiwan
  • +1 more
Dec 27, 2022

Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer Trial in Singapore (Oral lenvatinib + Intravenous (IV)

Not yet recruiting
  • Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
  • Oral lenvatinib + Intravenous (IV) pembrolizumab + Oral letrozole
  • Singapore, Singapore
    National Cancer Centre Singapore
Oct 13, 2022

NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Nintedanib)

Active, not recruiting
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 3, 2023

METAstatic Gastrointestinal Stromal Tumors (METAGIST)

Recruiting
  • Gastro Intestinal Stromal Tumor
  • oral tyrosine-kinase inhibitors (TKI) of KIT and PDGFR as per recommendations
  • Bordeaux, France
    Institut Bergonié, Comprehensive Cancer Center
Dec 1, 2022

Hepatocellular Carcinoma Trial in Shanghai (lenvatinib, TACE)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Shanghai, China
    Huashan hospital
Jul 29, 2022

Mesothelioma, Malignant Trial in Rozzano (Gemcitabine, Imatinib mesylate)

Completed
  • Mesothelioma, Malignant
  • Rozzano, MI, Italy
    Istituto Clinico Humanitas
Jan 20, 2021

Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)

Terminated
Has Results
  • Glioma
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Sep 26, 2022

Liver Fibrosis Trial in Tehran (Imatinib 200mg, Placebo)

Active, not recruiting
  • Liver Fibrosis
  • Imatinib 200mg
  • Placebo
  • Tehran, Iran, Islamic Republic of
    Research Institute of Gastroenterology & Liver Diseases
Jan 24, 2022

Cellular Mechanisms Involved in Muscle Pathology

Recruiting
  • Muscle Strain, Lower Leg
  • +3 more
  • Biopsies
  • Copenhagen, Denmark
    Institute of Sports Medicine Copenhagen, Bispebjerg Hospital, Ni
Apr 5, 2023

Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers Trial in Worldwide (DCC-2618)

Active, not recruiting
  • Gastrointestinal Stromal Tumors
  • +2 more
  • Scottsdale, Arizona
  • +25 more
Apr 16, 2021

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

Terminated
  • Hepatitis B, Chronic
  • Hillsborough, New Jersey
  • +11 more
Dec 28, 2022

Screening for Alpha Thalassemia in Healthy Volunteers

Recruiting
  • Alpha Thalassemia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Frontal Alpha Asymmetry and Pediatric Emergence Delirium

    Not yet recruiting
    • Emergence Delirium
    • Ophthalmic surgery
    • General anesthesia
    • (no location specified)
    Apr 5, 2023

    Alpha-1 Antitrypsin Deficiency Trial in Gainesville (Alpha-1 Antitrypsin Genotype)

    Recruiting
    • Alpha-1 Antitrypsin Deficiency
    • Alpha-1 Antitrypsin Genotype
    • Gainesville, Florida
      University of Florida
    Nov 2, 2022

    Allergic Bronchiolitis Trial (Serum)

    Not yet recruiting
    • Allergic Bronchiolitis
    • Serum
    • (no location specified)
    Nov 14, 2023

    Rheumatoid Arthritis Trial in Canada, United States (ISIS 104838)

    Completed
    • Rheumatoid Arthritis
    • ISIS 104838
    • Birmingham, Alabama
    • +30 more
    Dec 1, 2022

    Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial (DaRT seeds insertion)

    Not yet recruiting
    • Pancreatic Cancer
    • +2 more
    • DaRT seeds insertion
    • (no location specified)
    Sep 5, 2023

    Pancreatic Ductal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Glioblastoma Multiforme Trial (68Ga-FF58, 177Lu-FF58)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +2 more
    • (no location specified)
    Jul 28, 2023

    Arthritis, Psoriatic Trial in Worldwide (Guselkumab, Golimumab, Placebo)

    Recruiting
    • Arthritis, Psoriatic
    • Phoenix, Arizona
    • +96 more
    Jan 17, 2023

    Iron, Alpha-Synuclein, and Lymphocyte-activation Gene-3 in

    Not yet recruiting
    • Brain Ischemia
    • Serum Iron
    • +7 more
    • Aswan, Egypt
      Aswan University Hospital
    Mar 7, 2023

    Stone, Urinary Trial in Hong Kong (Silodosin, Tamsulosin)

    Recruiting
    • Stone, Urinary
    • Hong Kong, Hong Kong
      Hong Kong
    Oct 3, 2022

    Kidney Transplant Trial in Canada, United States (Infliximab, Methylprednisolone, Mycophenolate Mofetil)

    Completed
    Has Results
    • Kidney Transplant
    • Infliximab
    • +9 more
    • Birmingham, Alabama
    • +14 more
    Jul 19, 2022

    Alpha-Thalassemia, Alpha Thalassemia Major, Alpha Thalassemia Minor Trial in San Francisco

    Recruiting
    • Alpha-Thalassemia
    • +2 more
      • San Francisco, California
        University of California San Francisco
      Oct 7, 2022